Suppr超能文献

人类尿液蛋白质组学:肾脏疾病中的分析技术与临床应用

Human Urine Proteomics: Analytical Techniques and Clinical Applications in Renal Diseases.

作者信息

Kalantari Shiva, Jafari Ameneh, Moradpoor Raheleh, Ghasemi Elmira, Khalkhal Ensieh

机构信息

Chronic Kidney Disease Research Center, Labbafinejad Hospital, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

Department of Basic Science, Faculty of Paramedical Sciences, Shahid Beheshti University of Medical Sciences, Tehran, Iran.

出版信息

Int J Proteomics. 2015;2015:782798. doi: 10.1155/2015/782798. Epub 2015 Nov 29.

Abstract

Urine has been in the center of attention among scientists of clinical proteomics in the past decade, because it is valuable source of proteins and peptides with a relative stable composition and easy to collect in large and repeated quantities with a noninvasive procedure. In this review, we discuss technical aspects of urinary proteomics in detail, including sample preparation, proteomic technologies, and their advantage and disadvantages. Several recent experiments are presented which applied urinary proteome for biomarker discovery in renal diseases including diabetic nephropathy, immunoglobulin A (IgA) nephropathy, focal segmental glomerulosclerosis, lupus nephritis, membranous nephropathy, and acute kidney injury. In addition, several available databases in urinary proteomics are also briefly introduced.

摘要

在过去十年中,尿液一直是临床蛋白质组学科学家关注的焦点,因为它是蛋白质和肽的宝贵来源,其组成相对稳定,且通过非侵入性程序易于大量且重复地收集。在本综述中,我们详细讨论了尿液蛋白质组学的技术方面,包括样品制备、蛋白质组学技术及其优缺点。还介绍了最近的几项实验,这些实验将尿液蛋白质组用于肾脏疾病生物标志物的发现,包括糖尿病肾病、免疫球蛋白A(IgA)肾病、局灶节段性肾小球硬化、狼疮性肾炎、膜性肾病和急性肾损伤。此外,还简要介绍了尿液蛋白质组学中的几个可用数据库。

相似文献

1
Human Urine Proteomics: Analytical Techniques and Clinical Applications in Renal Diseases.
Int J Proteomics. 2015;2015:782798. doi: 10.1155/2015/782798. Epub 2015 Nov 29.
2
Urinary proteomics as a novel tool for biomarker discovery in kidney diseases.
J Zhejiang Univ Sci B. 2010 Apr;11(4):227-37. doi: 10.1631/jzus.B0900327.
3
Biomarker discovery in glomerular diseases using urinary proteomics.
Proteomics Clin Appl. 2008 Oct;2(10-11):1413-21. doi: 10.1002/prca.200800036. Epub 2008 Aug 28.
5
Quantification of molecular heterogeneity in kidney tissue by targeted proteomics.
J Proteomics. 2019 Feb 20;193:85-92. doi: 10.1016/j.jprot.2018.03.001. Epub 2018 Mar 6.
6
Urinary Protein and Peptide Markers in Chronic Kidney Disease.
Int J Mol Sci. 2021 Nov 9;22(22):12123. doi: 10.3390/ijms222212123.
7
Mining the human urine proteome for monitoring renal transplant injury.
Kidney Int. 2016 Jun;89(6):1244-52. doi: 10.1016/j.kint.2015.12.049. Epub 2016 Mar 4.
8
Urinary proteome in a snapshot: normal urine and glomerulonephritis.
J Nephrol. 2013 Jul-Aug;26(4):610-6. doi: 10.5301/jn.5000233. Epub 2012 Oct 12.
9
Acquired glomerular lesions in patients with Down syndrome.
Hum Pathol. 2012 Jan;43(1):81-8. doi: 10.1016/j.humpath.2011.04.009. Epub 2011 Jul 5.
10
Urine exosomal ceruloplasmin: a potential early biomarker of underlying kidney disease.
Clin Exp Nephrol. 2019 Aug;23(8):1013-1021. doi: 10.1007/s10157-019-01734-5. Epub 2019 Apr 6.

引用本文的文献

1
Proteomic Insights into Bacterial Responses to Antibiotics: A Narrative Review.
Int J Mol Sci. 2025 Jul 27;26(15):7255. doi: 10.3390/ijms26157255.
2
Porous perspectives: a comprehensive review of medullary sponge kidney.
Int Urol Nephrol. 2025 Apr 26. doi: 10.1007/s11255-025-04531-0.
4
Urine Proteomics Profiling Identifies Novel Acute Pancreatitis Diagnostic Biomarkers in a Pediatric Population.
Gastroenterology. 2024 Oct;167(5):1019-1021.e2. doi: 10.1053/j.gastro.2024.05.015. Epub 2024 May 24.
5
Recent progress in mass spectrometry-based urinary proteomics.
Clin Proteomics. 2024 Feb 22;21(1):14. doi: 10.1186/s12014-024-09462-z.
6
Circulating Proteins as Diagnostic Markers in Gastric Cancer.
Int J Mol Sci. 2023 Nov 29;24(23):16931. doi: 10.3390/ijms242316931.
9
Urinary Proteomics for Discovery of Gastric Cancer Biomarkers to Enable Precision Clinical Oncology.
OMICS. 2023 Aug;27(8):361-371. doi: 10.1089/omi.2023.0077. Epub 2023 Aug 9.
10
Analysis of urine differential proteins in patients with allergic rhinitis.
Heliyon. 2023 Jun 17;9(6):e17323. doi: 10.1016/j.heliyon.2023.e17323. eCollection 2023 Jun.

本文引用的文献

2
Data Analysis Strategies for Protein Microarrays.
Microarrays (Basel). 2012 Aug 6;1(2):64-83. doi: 10.3390/microarrays1020064.
3
Increased expression of lysosome membrane protein 2 in glomeruli of patients with idiopathic membranous nephropathy.
Proteomics. 2015 Nov;15(21):3722-30. doi: 10.1002/pmic.201500127. Epub 2015 Sep 28.
4
Comparison of Depletion Strategies for the Enrichment of Low-Abundance Proteins in Urine.
PLoS One. 2015 Jul 24;10(7):e0133773. doi: 10.1371/journal.pone.0133773. eCollection 2015.
7
Assessment of cell-cycle arrest biomarkers to predict early and delayed acute kidney injury.
Dis Markers. 2015;2015:158658. doi: 10.1155/2015/158658. Epub 2015 Mar 18.
8
Comparative proteomic analysis of membranous nephropathy biopsy tissues using quantitative proteomics.
Exp Ther Med. 2015 Mar;9(3):805-810. doi: 10.3892/etm.2015.2197. Epub 2015 Jan 21.
9
Soluble CD36 in plasma and urine: a plausible prognostic marker for diabetic nephropathy.
J Diabetes Complications. 2015 Apr;29(3):400-6. doi: 10.1016/j.jdiacomp.2014.12.012. Epub 2014 Dec 31.
10
Changes in urine proteome accompanying diabetic nephropathy progression.
Pol Arch Med Wewn. 2015;125(1-2):27-38. doi: 10.20452/pamw.2640. Epub 2015 Jan 12.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验